The neurotrophic factor receptor ‘REarranged during Transfection’ (Ret) and its major ligand, Glial cell line-Derived Neurotrophic Factor (GDNF), have established roles in axon growth, enteric nervous system and kidney development, and cancer progression. This evidence concerns the gene RET and cancer.